Equine Health Market Size, Share, Growth, Report, 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Equine Health Market Size Analysis

Global Equine Health Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Vaccines
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Parasiticides
    1. Parasiticides By Value
  3. Anti-infectives
    1. Anti-infectives By Value
  4. Anti-inflammatory & Analgesics
    1. Anti-inflammatory & Analgesics By Value
  5. Others
    1. Others By Value
4. Medicinal Feed Additives
  1. By Value
5. Orthobiologics
  1. By Value
6. Diagnostics
  1. By Value
7. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Musculoskeletal Disorders
  1. By Value
3. Parasitic Infections
  1. By Value
4. Equine Herpes Virus
  1. By Value
5. Equine Viral Arteritis (EVA)
  1. By Value
6. Equine Influenza
  1. By Value
7. West Nile Virus
  1. By Value
8. Tetanus
  1. By Value
9. Other Indications
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary Hospitals & Clinics
  1. By Value
3. E-commerce
  1. By Value
4. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Vaccines
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Parasiticides
    1. Parasiticides By Value
  3. Anti-infectives
    1. Anti-infectives By Value
  4. Anti-inflammatory & Analgesics
    1. Anti-inflammatory & Analgesics By Value
  5. Others
    1. Others By Value
4. Medicinal Feed Additives
  1. By Value
5. Orthobiologics
  1. By Value
6. Diagnostics
  1. By Value
7. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Musculoskeletal Disorders
  1. By Value
3. Parasitic Infections
  1. By Value
4. Equine Herpes Virus
  1. By Value
5. Equine Viral Arteritis (EVA)
  1. By Value
6. Equine Influenza
  1. By Value
7. West Nile Virus
  1. By Value
8. Tetanus
  1. By Value
9. Other Indications
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary Hospitals & Clinics
  1. By Value
3. E-commerce
  1. By Value
4. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Vaccines
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Parasiticides
      1. Parasiticides By Value
    3. Anti-infectives
      1. Anti-infectives By Value
    4. Anti-inflammatory & Analgesics
      1. Anti-inflammatory & Analgesics By Value
    5. Others
      1. Others By Value
  4. Medicinal Feed Additives
    1. By Value
  5. Orthobiologics
    1. By Value
  6. Diagnostics
    1. By Value
  7. Others
    1. By Value
2. By Indication
  1. Introduction
    1. Indication By Value
  2. Musculoskeletal Disorders
    1. By Value
  3. Parasitic Infections
    1. By Value
  4. Equine Herpes Virus
    1. By Value
  5. Equine Viral Arteritis (EVA)
    1. By Value
  6. Equine Influenza
    1. By Value
  7. West Nile Virus
    1. By Value
  8. Tetanus
    1. By Value
  9. Other Indications
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary Hospitals & Clinics
    1. By Value
  3. E-commerce
    1. By Value
  4. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Vaccines
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Parasiticides
    1. Parasiticides By Value
  3. Anti-infectives
    1. Anti-infectives By Value
  4. Anti-inflammatory & Analgesics
    1. Anti-inflammatory & Analgesics By Value
  5. Others
    1. Others By Value
4. Medicinal Feed Additives
  1. By Value
5. Orthobiologics
  1. By Value
6. Diagnostics
  1. By Value
7. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Musculoskeletal Disorders
  1. By Value
3. Parasitic Infections
  1. By Value
4. Equine Herpes Virus
  1. By Value
5. Equine Viral Arteritis (EVA)
  1. By Value
6. Equine Influenza
  1. By Value
7. West Nile Virus
  1. By Value
8. Tetanus
  1. By Value
9. Other Indications
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary Hospitals & Clinics
  1. By Value
3. E-commerce
  1. By Value
4. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Vaccines
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Parasiticides
      1. Parasiticides By Value
    3. Anti-infectives
      1. Anti-infectives By Value
    4. Anti-inflammatory & Analgesics
      1. Anti-inflammatory & Analgesics By Value
    5. Others
      1. Others By Value
  4. Medicinal Feed Additives
    1. By Value
  5. Orthobiologics
    1. By Value
  6. Diagnostics
    1. By Value
  7. Others
    1. By Value
2. By Indication
  1. Introduction
    1. Indication By Value
  2. Musculoskeletal Disorders
    1. By Value
  3. Parasitic Infections
    1. By Value
  4. Equine Herpes Virus
    1. By Value
  5. Equine Viral Arteritis (EVA)
    1. By Value
  6. Equine Influenza
    1. By Value
  7. West Nile Virus
    1. By Value
  8. Tetanus
    1. By Value
  9. Other Indications
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary Hospitals & Clinics
    1. By Value
  3. E-commerce
    1. By Value
  4. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Vaccines
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Parasiticides
    1. Parasiticides By Value
  3. Anti-infectives
    1. Anti-infectives By Value
  4. Anti-inflammatory & Analgesics
    1. Anti-inflammatory & Analgesics By Value
  5. Others
    1. Others By Value
4. Medicinal Feed Additives
  1. By Value
5. Orthobiologics
  1. By Value
6. Diagnostics
  1. By Value
7. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Musculoskeletal Disorders
  1. By Value
3. Parasitic Infections
  1. By Value
4. Equine Herpes Virus
  1. By Value
5. Equine Viral Arteritis (EVA)
  1. By Value
6. Equine Influenza
  1. By Value
7. West Nile Virus
  1. By Value
8. Tetanus
  1. By Value
9. Other Indications
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary Hospitals & Clinics
  1. By Value
3. E-commerce
  1. By Value
4. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Vaccines
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Parasiticides
      1. Parasiticides By Value
    3. Anti-infectives
      1. Anti-infectives By Value
    4. Anti-inflammatory & Analgesics
      1. Anti-inflammatory & Analgesics By Value
    5. Others
      1. Others By Value
  4. Medicinal Feed Additives
    1. By Value
  5. Orthobiologics
    1. By Value
  6. Diagnostics
    1. By Value
  7. Others
    1. By Value
2. By Indication
  1. Introduction
    1. Indication By Value
  2. Musculoskeletal Disorders
    1. By Value
  3. Parasitic Infections
    1. By Value
  4. Equine Herpes Virus
    1. By Value
  5. Equine Viral Arteritis (EVA)
    1. By Value
  6. Equine Influenza
    1. By Value
  7. West Nile Virus
    1. By Value
  8. Tetanus
    1. By Value
  9. Other Indications
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary Hospitals & Clinics
    1. By Value
  3. E-commerce
    1. By Value
  4. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Vaccines
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Parasiticides
    1. Parasiticides By Value
  3. Anti-infectives
    1. Anti-infectives By Value
  4. Anti-inflammatory & Analgesics
    1. Anti-inflammatory & Analgesics By Value
  5. Others
    1. Others By Value
4. Medicinal Feed Additives
  1. By Value
5. Orthobiologics
  1. By Value
6. Diagnostics
  1. By Value
7. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Musculoskeletal Disorders
  1. By Value
3. Parasitic Infections
  1. By Value
4. Equine Herpes Virus
  1. By Value
5. Equine Viral Arteritis (EVA)
  1. By Value
6. Equine Influenza
  1. By Value
7. West Nile Virus
  1. By Value
8. Tetanus
  1. By Value
9. Other Indications
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary Hospitals & Clinics
  1. By Value
3. E-commerce
  1. By Value
4. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Vaccines
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Parasiticides
      1. Parasiticides By Value
    3. Anti-infectives
      1. Anti-infectives By Value
    4. Anti-inflammatory & Analgesics
      1. Anti-inflammatory & Analgesics By Value
    5. Others
      1. Others By Value
  4. Medicinal Feed Additives
    1. By Value
  5. Orthobiologics
    1. By Value
  6. Diagnostics
    1. By Value
  7. Others
    1. By Value
2. By Indication
  1. Introduction
    1. Indication By Value
  2. Musculoskeletal Disorders
    1. By Value
  3. Parasitic Infections
    1. By Value
  4. Equine Herpes Virus
    1. By Value
  5. Equine Viral Arteritis (EVA)
    1. By Value
  6. Equine Influenza
    1. By Value
  7. West Nile Virus
    1. By Value
  8. Tetanus
    1. By Value
  9. Other Indications
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary Hospitals & Clinics
    1. By Value
  3. E-commerce
    1. By Value
  4. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Vaccines
  1. By Value
3. Pharmaceuticals
  1. By Value
  2. Parasiticides
    1. Parasiticides By Value
  3. Anti-infectives
    1. Anti-infectives By Value
  4. Anti-inflammatory & Analgesics
    1. Anti-inflammatory & Analgesics By Value
  5. Others
    1. Others By Value
4. Medicinal Feed Additives
  1. By Value
5. Orthobiologics
  1. By Value
6. Diagnostics
  1. By Value
7. Others
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Musculoskeletal Disorders
  1. By Value
3. Parasitic Infections
  1. By Value
4. Equine Herpes Virus
  1. By Value
5. Equine Viral Arteritis (EVA)
  1. By Value
6. Equine Influenza
  1. By Value
7. West Nile Virus
  1. By Value
8. Tetanus
  1. By Value
9. Other Indications
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary Hospitals & Clinics
  1. By Value
3. E-commerce
  1. By Value
4. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Vaccines
    1. By Value
  3. Pharmaceuticals
    1. By Value
    2. Parasiticides
      1. Parasiticides By Value
    3. Anti-infectives
      1. Anti-infectives By Value
    4. Anti-inflammatory & Analgesics
      1. Anti-inflammatory & Analgesics By Value
    5. Others
      1. Others By Value
  4. Medicinal Feed Additives
    1. By Value
  5. Orthobiologics
    1. By Value
  6. Diagnostics
    1. By Value
  7. Others
    1. By Value
2. By Indication
  1. Introduction
    1. Indication By Value
  2. Musculoskeletal Disorders
    1. By Value
  3. Parasitic Infections
    1. By Value
  4. Equine Herpes Virus
    1. By Value
  5. Equine Viral Arteritis (EVA)
    1. By Value
  6. Equine Influenza
    1. By Value
  7. West Nile Virus
    1. By Value
  8. Tetanus
    1. By Value
  9. Other Indications
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary Hospitals & Clinics
    1. By Value
  3. E-commerce
    1. By Value
  4. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Equine Health Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Zoetis (US)
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Merck Animal Health (US)
Boehringer Ingelheim Animal Health (Germany)
Elanco Animal Health (US)
Ceva Santé Animale (France)
Virbac (France)
Dechra Pharmaceuticals (UK)
Vetoquinol (France)
IDEXX Laboratories (US)
Phibro Animal Health Corporation (US)
Neogen Corporation (US)
Norbrook Laboratories (UK)
HIPRA (Spain)
Bimeda (Ireland)
Heska Corporation (US)
Covetrus (US)
Thermo Fisher Scientific Animal Health (US)
Mars Veterinary Health (US)
PetIQ (US)
Animalcare Group (UK)

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Debashree B

Healthcare Lead